TriMas Projects 2026 EPS of $1.60 to $1.70 and Sales Growth Following Rapak Divestiture
TriMas (TRS) has provided long-term financial guidance, projecting earnings per share (EPS) between $1.60 and $1.70 for the year 2026. The company expects to achieve annual sales growth in the range of 4% to 6%, a trajectory following the strategic divestiture of its Rapak business unit. During the Q3 earnings call, CEO Thomas Snyder emphasized that current results do not yet fully capture the impact of ongoing cost-reduction initiatives and operational execution. Management remains optimistic that these internal actions will drive improved margins and value as the company transitions to its new portfolio structure.
Tickers: $TRS
Topics: cost reduction earnings management commentary operational execution
Read the full article at Seeking Alpha
Part of the story Interparfums Projects $1.49 Billion in 2026 Sales and Reaffirms EPS Guidance (14 articles)